Cambridge Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,617
| Closed | -$1.04M | – | 178 |
|
|
2022
Q1 | $1.04M | Buy |
22,617
+400
| +2% | +$18.4K | 0.25% | 65 |
|
|
2021
Q4 | $1.36M | Sell |
22,217
-698
| -3% | -$42.8K | 0.31% | 57 |
|
|
2021
Q3 | $1.71M | Buy |
22,915
+386
| +2% | +$28.8K | 0.42% | 35 |
|
|
2021
Q2 | $2.08M | Buy |
22,529
+4,278
| +23% | +$396K | 0.5% | 30 |
|
|
2021
Q1 | $1.62M | Buy |
18,251
+2,902
| +19% | +$257K | 0.41% | 40 |
|
|
2020
Q4 | $1.43M | Buy |
15,349
+903
| +6% | +$84.2K | 0.39% | 43 |
|
|
2020
Q3 | $920K | Buy |
14,446
+730
| +5% | +$46.5K | 0.27% | 65 |
|
|
2020
Q2 | $715K | Buy |
13,716
+1,648
| +14% | +$85.9K | 0.22% | 74 |
|
|
2020
Q1 | $377K | Sell |
12,068
-6,558
| -35% | -$205K | 0.14% | 95 |
|
|
2019
Q4 | $624K | Sell |
18,626
-282
| -1% | -$9.45K | 0.19% | 83 |
|
|
2019
Q3 | $558K | Buy |
18,908
+225
| +1% | +$6.64K | 0.18% | 78 |
|
|
2019
Q2 | $644K | Buy |
18,683
+408
| +2% | +$14.1K | 0.21% | 78 |
|
|
2019
Q1 | $601K | Sell |
18,275
-500
| -3% | -$16.4K | 0.2% | 81 |
|
|
2018
Q4 | $450K | Buy |
18,775
+5,775
| +44% | +$138K | 0.17% | 90 |
|
|
2018
Q3 | $435K | Buy |
13,000
+4,100
| +46% | +$137K | 0.15% | 91 |
|
|
2018
Q2 | $259K | Buy |
8,900
+450
| +5% | +$13.1K | 0.09% | 121 |
|
|
2018
Q1 | $218K | Buy |
+8,450
| New | +$218K | 0.08% | 129 |
|